Filing Details
- Accession Number:
- 0001209191-22-043524
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-29 16:26:53
- Reporting Period:
- 2022-07-26
- Accepted Time:
- 2022-07-29 16:26:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1881007 | E. Jeff Knight | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-20 | 1,152 | $17.44 | 6,102 | No | 4 | J | Direct | |
| Common Stock | Disposition | 2022-07-26 | 1,152 | $20.70 | 4,950 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b)pursuant to Rule 16b-3(c).
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average salesprice of $20.7004 per share. The range of actual sales prices on the transaction date was $20.69 to $20.7016 per share. Detailed information onthe exact number of shares sold at each price can be obtained from the issuer upon request.
Billionaire Hedge Funds
